Literature DB >> 13978068

Cyclophosphamide. A clinical study.

J SOLOMON, M J ALEXANDER, J L STEINFELD.   

Abstract

Entities:  

Keywords:  CYCLOPHOSPHAMIDE

Mesh：

Substances：

Year:  1963        PMID： 13978068     DOI： 10.1001/jama.1963.03700030041009

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  8 in total

1.  Mechanisms of Lymphoma Clearance Induced by High-Dose Alkylating Agents.

Authors:  Chen Lossos; Yunpeng Liu; Kellie E Kolb; Amanda L Christie; Alexandria Van Scoyk; Sanjay M Prakadan; Kay Shigemori; Kristen E Stevenson; Sara Morrow; Olivia D Plana; Cameron Fraser; Kristen L Jones; Huiyun Liu; Christian P Pallasch; Rebecca Modiste; Quang-De Nguyen; Jeffrey W Craig; Elizabeth A Morgan; Francisco Vega; Jon C Aster; Kristopher A Sarosiek; Alex K Shalek; Michael T Hemann; David M Weinstock
Journal:  Cancer Discov       Date:  2019-04-30       Impact factor: 39.397

Review 2.  Chemotherapy of acute leukemia in childhood.

Authors:  K K Khanna
Journal:  Indian J Pediatr       Date:  1968-12       Impact factor: 1.967

3.  [Long term treatment of advanced lymphogranulomatosis with vinblastine sulfate].

Authors:  E Schulz; W Jüngling; K Hausmann
Journal:  Klin Wochenschr       Date:  1969-02-15

4.  Ifosfamide chemotherapy for pancreatic carcinoma.

Authors:  L H Einhorn; P J Loehrer
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

5.  Oxazaphosphorine bioactivation and detoxification The role of xenobiotic receptors.

Authors:  Duan Wang; Hongbing Wang
Journal:  Acta Pharm Sin B       Date:  2012-04-01       Impact factor: 11.413

6.  [Inhibition of serum cholinesterase by cyclophosphamide (endoxan)].

Authors:  H Wolff
Journal:  Klin Wochenschr       Date:  1965-08-01

7.  Approving cancer treatments based on endpoints other than overall survival: an analysis of historical data using the PACE Continuous Innovation Indicators™ (CII).

Authors:  Neon Brooks; Mario Campone; Silvia Paddock; Scott Shortenhaus; David Grainger; Jacqueline Zummo; Samuel Thomas; Rose Li
Journal:  Drugs Context       Date:  2017-11-15

8.  Modulation of ERCC1-XPF Heterodimerization Inhibition via Structural Modification of Small Molecule Inhibitor Side-Chains.

Authors:  Claudia Weilbeer; David Jay; James C Donnelly; Francesco Gentile; Feridoun Karimi-Busheri; Xiaoyan Yang; Rajam S Mani; Yaping Yu; Ahmed H Elmenoufy; Khaled H Barakat; Jack A Tuszynski; Michael Weinfeld; Frederick G West
Journal:  Front Oncol       Date:  2022-03-17       Impact factor: 6.244
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.